Literature DB >> 158445

Interventricular septal thickness and left ventricular hypertrophy. An echocardiographic study.

S Kansal, D Roitman, L T Sheffield.   

Abstract

Septal and left ventricular posterior wall (LVPW) thicknesses and their ratios were studied at the left ventricular outflow tract and left ventricular cavity in 66 patients with echocardiographically diagnosed left ventricular concentric hypertrophy, 20 with idiopathic hypertrophic subaortic stenosis (IHSS), and 34 normal subjects. Concentric hypertrophy was due to hypertension in 41 subjects and to valvular disease in 15 subjects. Septal thickness in normal subjects was related to body surface area (p less than 0.02). In 12% of normal subjects, 39% of patients with concentric hypertrophy and 95% with IHSS, the septal/LVPW ratio was greater than or equal to 1.3. Thirty-two percent of patients with hypertension, 78% with aortic stenosis, and 60% with aortic insufficiency had septal/LVPW ratios greater than or equal to 1.3 at left ventricular midcavity level. In conclusion, a septal/LVPW thickness ratio of greater than or equal to 1.3 is common in patients with concentric left ventricular hypertrophy and may also occur in normal subjects. A ratio greater than or equal to 1.5 may be more specific for genetically determined asymmetric septal hypertrophy.

Entities:  

Mesh:

Year:  1979        PMID: 158445     DOI: 10.1161/01.cir.60.5.1058

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

1.  A case of hypereosinophilic syndrome with asymmetric septal hypertrophy.

Authors:  S Nunoda; A Genda
Journal:  Heart Vessels       Date:  1991       Impact factor: 2.037

2.  The effect of geographical indices on left ventricular structure in healthy Han Chinese population.

Authors:  Minyi Cen; Miao Ge; Yonglin Liu; Congxia Wang; Shaofang Yang
Journal:  Int J Biometeorol       Date:  2016-07-28       Impact factor: 3.787

3.  Acromegalic cardiopathy improves after treatment with increasing doses of octreotide.

Authors:  J L Pereira; M J Rodriguez-Puras; A Leal-Cerro; A Martinez; P P Garcia-Luna; I Gavilan; A Pumar; R Astorga
Journal:  J Endocrinol Invest       Date:  1991-01       Impact factor: 4.256

Review 4.  The 'athletic heart syndrome'. A critical review.

Authors:  K P George; L A Wolfe; G W Burggraf
Journal:  Sports Med       Date:  1991-05       Impact factor: 11.136

5.  Familial hypertrophic cardiomyopathy: vectorcardiographic findings in echocardiographically unaffected relative.

Authors:  F Loperfido; R Fiorilli; A Digaetano; M Di Gennaro; P Santarelli; F Bellocci; E Coppola; P Zecchi
Journal:  Br Heart J       Date:  1982-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.